Atezolizumab and bevacizumab in patients with relapsed mesothelioma: MIST4-a phase IIa trial with cellular and molecular correlates of efficacy.
JOURNAL OF CLINICAL ONCOLOGY(2022)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF CLINICAL ONCOLOGY(2022)